Back to Search
ALAN MCINNES, M.D.
M.D.
Ophthalmology Physician
NPI: 1942345228IndividualAccepts Medicare
Specialties, Licenses & Credentials
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
A98662(CA)5755878-1205(UT)M11139(ID)
Education
UNIVERSITY OF UTAH SCHOOL OF MEDICINE
Class of 2000
Research & Publications (15)
The sounds of silence: language, cognition, and anxiety in selective mutism.
PMID 17712242·J Am Acad Child Adolesc Psychiatry·2007
8-other
Preliminary evidence of beneficial effects of methylphenidate on listening comprehension in children with attention-deficit/hyperactivity disorder.
PMID 17343552·J Child Adolesc Psychopharmacol·2007
4-observational
European origin of Bradyrhizobium populations infecting lupins and serradella in soils of Western Australia and South Africa.
PMID 16269740·Appl Environ Microbiol·2005
8-other
When silence is not golden: an integrated approach to selective mutism.
PMID 16155858·Semin Speech Lang·2005
8-other
Narrative skills in children with selective mutism: an exploratory study.
PMID 15719897·Am J Speech Lang Pathol·2004
8-other
A clinical study and the national service framework for diabetes.
PMID 15516100·J Tissue Viability·2004
5-case
Characterizing selective mutism: is it more than social anxiety?
PMID 14625881·Depress Anxiety·2003
4-observational
Cochrane Stroke Group 10 years on: progress to date and future challenges.
PMID 14500941·Stroke·2003
8-other
Listening comprehension and working memory are impaired in attention-deficit hyperactivity disorder irrespective of language impairment.
PMID 12831231·J Abnorm Child Psychol·2003
8-other
Contribution of Stroke to the Cochrane Stroke Group Trials Register.
PMID 12574542·Stroke·2003
8-other
A phase I and pharmacokinetic study of capecitabine in combination with epirubicin and cisplatin in patients with inoperable oesophago-gastric adenocarcinoma.
PMID 12196374·Ann Oncol·2002
3-trial
A phase II study of epirubicin, cisplatin and raltitrexed combination chemotherapy (ECT) in patients with advanced oesophageal and gastric adenocarcinoma.
PMID 11762812·Ann Oncol·2001
3-trial
Striatal cannabinoid CB1 receptor mRNA expression is decreased in the reserpine-treated rat model of Parkinson's disease.
PMID 11358453·Exp Neurol·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 323 E RIVERSIDE DR, SUITE 136, EAGLE
EAGLE, ID 83616 - Phone
- (208) 939-2939
Quick Facts
- NPI
- 1942345228
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 26
- Publications
- 15
Are you this provider?
Claim Your Profile